Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Kathy S. Albain, William E. Barlow, Steven Shak, Gabriel N. Hortobagyi, Robert B. Livingston, I. Tien Yeh, Peter Ravdin, Roberto Bugarini, Frederick L. Baehner, Nancy E. Davidson, George W. Sledge, Eric P. Winer, Clifford Hudis, James N. Ingle, Edith A. Perez, Kathleen I. Pritchard, Lois Shepherd, Julie R. Gralow, Carl Yoshizawa, D. Craig AllredC. Kent Osborne, Daniel F. Hayes

Research output: Contribution to journal › Article › peer-review

966 Scopus citations

Fingerprint

Dive into the research topics of 'Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial'. Together they form a unique fingerprint.

Medicine & Life Sciences